1. Home
  2. KYIV vs TVTX Comparison

KYIV vs TVTX Comparison

Compare KYIV & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KYIV

Kyivstar Group Ltd.

N/A

Current Price

$12.22

Market Cap

3.1B

Sector

N/A

ML Signal

N/A

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$29.69

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KYIV
TVTX
Founded
N/A
2008
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KYIV
TVTX
Price
$12.22
$29.69
Analyst Decision
Strong Buy
Analyst Count
0
15
Target Price
N/A
$37.21
AVG Volume (30 Days)
N/A
3.2M
Earning Date
N/A
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$435,826,000.00
Revenue This Year
N/A
$120.02
Revenue Next Year
N/A
$37.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
114.22
52 Week Low
N/A
$12.91
52 Week High
N/A
$42.13

Technical Indicators

Market Signals
Indicator
KYIV
TVTX
Relative Strength Index (RSI) N/A 37.65
Support Level N/A $26.78
Resistance Level N/A $29.31
Average True Range (ATR) 0.00 2.37
MACD 0.00 -0.62
Stochastic Oscillator 0.00 39.37

Price Performance

Historical Comparison
KYIV
TVTX

About KYIV Kyivstar Group Ltd.

Kyivstar Group Ltd is engaged in mobile communication.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: